1Taylor D,Mace S,Mir S,et al.A prescription survey of the use of atypical antipsychotic for hospital inpatients in the Untied Kingdom. Int J Psychiatry Clin Pract,2000,4( 1 ):41-46.
4Van Brunt DL,Gibson PJ,Ramsey JL,et al.Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1977-2000. Med Gen Med,2003,5(3):16.
5Keks NA,Altson K,Hope J,et al.Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust NZ J Psychiatry, 1999,33(6):896-901.
6Mond J,Morice R,Owen C,et al. Use of antipsychotic medications in Australia between July 1995 and December 2001.Aust NZ J Psychiatry, 2003,37 ( 1 ):55-61.
7Santamaria B,Perez M,Montero D,et al. Use of antipsychotic agents in Spain through 1985-2000. Eur Psychiatry,2002,17(8):471-476.
8Mclntyre RS, Macini DA, Basile VS.Mechanisms of antipsychoticinduced weight gain.J Clin Psychiatry, 2001,62 ( Suppl ) :23-29.
10Newcomer JW,Haupt DW,Fucetola R,et al.Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry,2002,59:337-345.
二级参考文献16
1Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
2Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
3Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
4Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
5Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.
6Conley RR, Love RC, Kelly DL, et al. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry, 1999, 156:863-868.
7Meltzer H.Side effects of antipsychotic medications: physician's choice of medication and patient compliance[editorial]. J Clin Psychiatry, 2000, 61 Suppl 8:3-66.
8McCombs JS, Nichol MB, Stimmel GL, et al. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry, 1999, 60 Suppl 19:5-11.
9Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neurop-sychopharmacol, 1998, 8:55 -66.
10Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic:a double-blind comparison with chlorpromazine. Arch Gen Psychiatry, 1988, 45:789-796.
